1. Home
  2. CUE vs KNRX Comparison

CUE vs KNRX Comparison

Compare CUE & KNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cue Biopharma Inc.

CUE

Cue Biopharma Inc.

HOLD

Current Price

$0.62

Market Cap

17.6M

Sector

Health Care

ML Signal

HOLD

KNRX

KNOREX LTD. Class A Ordinary Shares

N/A

Current Price

$1.31

Market Cap

42.6M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
CUE
KNRX
Founded
2014
2009
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
17.6M
42.6M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
CUE
KNRX
Price
$0.62
$1.31
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
19.4M
68.0K
Earning Date
05-11-2026
06-12-2026
Dividend Yield
N/A
N/A
EPS Growth
61.11
N/A
EPS
N/A
N/A
Revenue
$27,466,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
195.75
N/A
52 Week Low
$0.17
$0.76
52 Week High
$1.03
$3.45

Technical Indicators

Market Signals
Indicator
CUE
KNRX
Relative Strength Index (RSI) 72.18 45.36
Support Level $0.24 $1.29
Resistance Level $0.66 $1.45
Average True Range (ATR) 0.11 0.20
MACD 0.05 -0.02
Stochastic Oscillator 70.92 27.32

Price Performance

Historical Comparison
CUE
KNRX

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.

About KNRX KNOREX LTD. Class A Ordinary Shares

Knorex Ltd is a B2B technology company providing programmatic advertising products and solutions to marketers to streamline and automate their advertising and marketing workflows. Its software offers marketers cost-effective solutions and productivity-enhancing capabilities to target audience across various advertising channels and devices through automated processes and algorithms, which is known as programmatic advertising. Its product, Knorex XPOSM, is a self-service enterprise-grade cloud platform with a suite of advertising management and execution (AMX) applications. The Company operates in one operating segment, which focuses on platform subscription fee, platform services, managed activations, and professional services.

Share on Social Networks: